A starter pack of Janssen Pharmaceuticals' rivaroxaban (Xarelto) will be available at pharmacies starting in October 2014.
A starter pack of Janssen Pharmaceuticals’ rivaroxaban (Xarelto) will be available at pharmacies starting in October 2014.
According to Janssen, the Xarelto Starter Pack will help guide physicians and patients through initial treatment for deep vein thrombosis (DVT) or pulmonary embolism (PE), for which the drug was initially approved in November 2012.
“Beyond our clinical trials we continue to pursue innovation that can help support patients,” said Paul Burton, MD, PhD, Vice President of Medical Affairs at Janssen, in a press release. “The starter pack will make a difference for patients impacted by blood clots by offering a 30-day supply of the drug in a new convenient package, which may help support patients as they transition from the hospital to out-patient care.”
The starter pack is designed for administration during the 30-day period when patients are most vulnerable to another DVT or PE event.
Xarelto is dosed twice-daily at 15 mg with food for the first 21 days, after which patients transition to once-daily doses at 20 mg with food for the remainder of their treatment.